Patients are bullish on the benefits of genAI, but still have qualms

US consumers report optimism regarding the potential of generative AI in healthcare, but trust issues limit its adoption, Deloitte’s 2024 survey reveals. While 66% believe AI could reduce waiting times and healthcare costs, distrust in AI outputs rose to 30%, hindering its use. To boost AI adoption, healthcare organizations must align the technology with patient values, involve clinicians as change agents, and ensure transparency and responsible use of user data.